Blocking an enzyme’s production restored brain growth and healthy behaviors in mice engineered to develop Angelman syndrome, pointing to a possible treatment target. Children with Angelman syndrome begin to show difficulties with thinking and movement at around 6 months of age. The rare condition occurs in approximately one in 20,000 births and is caused by […]
A Single Enzyme Could Hold the Key to Treating a Devastating Brain Disorder
